FOXP3 and pulmonary emphysema: It has been revealed that CV reduces emphysema in chronic obstructive pulmonary disease (COPD) and increases the anti-inflammatory cytokines and expression of the genes forkhead box P3 (FOXP3) and interferon gamma (IFNγ) in a model of asthmatic mice [58,85].